A director at Steris Plc sold 1,682 shares at 217.320USD and the significance rating of the trade was 55/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly show...
Summary GOJO Industries Inc - Company Profile and SWOT Analysis, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company. Key Highlights GOJO Industries Inc (GOJO Industries) is a producer and marketer of skin health and hygiene products. The company's product portfolio includes hand sanitizers, hand soaps, hand cleaning and skin car...
Full Article at IIR has reaffirmed its Recommended rating for PIA after undertaking a review post the appointment of a new Portfolio Manager, Harding Loevner. The full report can be found on the IIR website. On 26 July 2021, Pengana International Equities Limited (PIA) announced a fully franked dividend of 1.35 cents per share for the June quarter. This represents an 8% increase on the March quarter dividend and takes the total dividends declared for FY21 of 5.1 cents per share, fully franked....
We believe management’s investment strategy at Steris has been instrumental in forming a narrow-moat enterprise, deploying capital into internal initiatives and acquisitions to fortify the firm’s position as the global leader in infection prevention. The 1997 purchase of Isomedix formed the foundation upon which the company built its leading position in contract sterilization services in the healthcare industry, capped by the acquisition of U.K.-based Synergy Health in 2015. We think this pi...
Steris reported another characteristically strong quarter, with organic constant currency revenue up nearly 7% in the period. We'll make some adjustments to our model but anticipate only a modest increase to our $101 fair value estimate. We saw impressive performance across the narrow-moat enterprise, although the comparable growth of 8% in its applied sterilization segment and 10% in healthcare services stood out to us in particular. Our valuation implies 19.9 times and 13.4 times our updated ...
Steris reported another characteristically strong quarter, with organic constant currency revenue up nearly 7% in the period. We'll make some adjustments to our model but anticipate only a modest increase to our $101 fair value estimate. We saw impressive performance across the narrow-moat enterprise, although the comparable growth of 8% in its applied sterilization segment and 10% in healthcare services stood out to us in particular. Our valuation implies 19.9 times and 13.4 times our updated ...
Steris reported another characteristically strong quarter, with organic constant currency revenue up nearly 7% in the period. We'll make some adjustments to our model but anticipate only a modest increase to our $101 fair value estimate. We saw impressive performance across the narrow-moat enterprise, although the comparable growth of 8% in its applied sterilization segment and 10% in healthcare services stood out to us in particular. Our valuation implies 19.9 times and 13.4 times our updated ...
Summary Marketline's Getinge AB Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capital raisings, venture capital investments, ownership and partnership transactions undertaken by Getinge AB since January2007. Marketline's Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic g...
Summary Marketline's Teleflex Incorporated Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capital raisings, venture capital investments, ownership and partnership transactions undertaken by Teleflex Incorporated since January2007. Marketline's Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the o...
Our outlook remains cautious and we continue to expect heightened volatility and a potential retest of the February 2018 lows over the next several weeks. Near-term we are monitoring for S&P 500 support near 2,600 (i.e., the October low) and resistance near 2,817 or the 100- and 50-day moving averages. In today's report we outline our current concerns along with developments that would cause us to become more constructive on the market. • Sector Relative Strength Rankings (RSRs) & Weighting ...
Narrow-moat Steris reported fiscal second-quarter results that were, on balance, in line with our expectations. The firm had a stellar quarter for capital equipment sales, with service and consumable revenue falling just shy of our forecast. We'll make some small changes to our model, mostly to incorporate a lower tax rate for the full year, but we're already more or less in line with management's raised revenue outlook. We don’t anticipate a change to our $101 fair value estimate, which impli...
Narrow-moat Steris reported fiscal second-quarter results that were, on balance, in line with our expectations. The firm had a stellar quarter for capital equipment sales, with service and consumable revenue falling just shy of our forecast. We'll make some small changes to our model, mostly to incorporate a lower tax rate for the full year, but we're already more or less in line with management's raised revenue outlook. We don’t anticipate a change to our $101 fair value estimate, which impli...
Key Points: Gold is breaking to a one month high. Watch for a U.S. dollar decline as market internals fade. Banks continue to weigh on the market. Software names are under pressure with many falling below their respective 200-day moving averages. Value appears to be winning out over growth as interest rates rise.
We believe management’s investment strategy at Steris has been instrumental in forming a narrow-moat enterprise, deploying capital into internal initiatives and acquisitions to fortify the firm’s position as the global leader in infection prevention. The firm’s 1997 purchase of Isomedix formed the foundation upon which the company built its leading position in contract sterilization services within the healthcare industry, capped by the acquisition of U.K.-based Synergy Health in 2015. We ...
Steris posted strong first-quarter results that were in line with our forecasts. We'll likely raise our fair value estimate by a mid-single-digit percentage for the narrow-moat company as we account for the cash flows received since our last update, but we don't intend to make any major changes to our model. The negative market reaction is probably attributable to the company's reported miss on operating profit, although the bottom line benefited from a more favorable tax rate. Elevated expense...
Steris posted strong first-quarter results that were in line with our forecasts. We'll likely raise our fair value estimate by a mid-single-digit percentage for the narrow-moat company as we account for the cash flows received since our last update, but we don't intend to make any major changes to our model. The negative market reaction is probably attributable to the company's reported miss on operating profit, although the bottom line benefited from a more favorable tax rate. Elevated expense...
Steris posted strong first-quarter results that were in line with our forecasts. We'll likely raise our fair value estimate by a mid-single-digit percentage for the narrow-moat company as we account for the cash flows received since our last update, but we don't intend to make any major changes to our model. The negative market reaction is probably attributable to the company's reported miss on operating profit, although the bottom line benefited from a more favorable tax rate. Elevated expense...
HOLD Adjusted EPS for 1Q19 (June) was up 17% YoY to a record $1.00 (vs $0.85), 3 cents above our figure due to a lower-than-anticipated tax rate, while operating income rose 8%, slightly below what we modeled; We are holding our EPS estimates at $4.72 for FY18 (vs the record $4.15 in FY18) and $5.32 for FY20; STERIS raised its quarterly dividend 3 cents (10%) today to 34 cents per share, for the 13th consecutive annual increase.
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.